ADVANCED ENZYME TECHNOLOGIES
Quarterly Results Analysis [Dec2023]
ADVANCED ENZYME TECHNOLOGIES Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹161 Cr | ₹158 Cr | ₹147 Cr | ₹139 Cr | ₹142 Cr | ₹139 Cr | ₹121 Cr | ₹132 Cr |
Expenses | ₹107 Cr | ₹107 Cr | ₹103 Cr | ₹95 Cr | ₹100 Cr | ₹99 Cr | ₹90 Cr | ₹91 Cr |
Operating Income | ₹54 Cr | ₹51 Cr | ₹44 Cr | ₹44 Cr | ₹42 Cr | ₹40 Cr | ₹31 Cr | ₹40 Cr |
Other Income | ₹14 Cr | ₹6 Cr | ₹7 Cr | ₹11 Cr | ₹9 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹8 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr |
Profit Before Tax | ₹59 Cr | ₹48 Cr | ₹41 Cr | ₹42 Cr | ₹40 Cr | ₹34 Cr | ₹24 Cr | ₹34 Cr |
Profit After Tax | ₹43 Cr | ₹35 Cr | ₹29 Cr | ₹32 Cr | ₹28 Cr | ₹26 Cr | ₹18 Cr | ₹25 Cr |
EPS | ₹3.74 | ₹3.08 | ₹2.58 | ₹2.87 | ₹2.63 | ₹2.34 | ₹1.60 | ₹2.19 |
Industry Peers & Returns | 1W | 1M | 1Y |
ADVANCED ENZYME TECHNOLOGIES | 2.3% | 11.4% | 53.3% |
SUN PHARMACEUTICAL INDUSTRIES | 1.1% | -6.6% | 56.7% |
CIPLA | 0.2% | -4.4% | 54.3% |
DR REDDYS LABORATORIES | 4.3% | 2.6% | 29.9% |
ZYDUS LIFESCIENCES | 2.2% | -4.6% | 86.6% |
DIVIS LABORATORIES | 4.8% | 18.9% | 23.9% |
MANKIND PHARMA | -1.4% | 1.4% | NA |
TORRENT PHARMACEUTICALS | -1.7% | 3% | 65.8% |
LUPIN | 4.1% | 3% | 131.2% |
ADVANCED ENZYME TECHNOLOGIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 1.96 % |
Y-o-Y | 13.25 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹161 Cr | 1.96 | |
Sep2023 | ₹158 Cr | 7.17 | |
Jun2023 | ₹147 Cr | 6.18 | |
Mar2023 | ₹139 Cr | -2.39 | |
Dec2022 | ₹142 Cr | 2.47 | |
Sep2022 | ₹139 Cr | 14.51 | |
Jun2022 | ₹121 Cr | -8.06 | |
Mar2022 | ₹132 Cr | - |
ADVANCED ENZYME TECHNOLOGIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 4.77 % |
Y-o-Y | 28.95 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹54 Cr | 4.77 | |
Sep2023 | ₹51 Cr | 16.58 | |
Jun2023 | ₹44 Cr | -0.30 | |
Mar2023 | ₹44 Cr | 5.89 | |
Dec2022 | ₹42 Cr | 5.07 | |
Sep2022 | ₹40 Cr | 28.29 | |
Jun2022 | ₹31 Cr | -23.30 | |
Mar2022 | ₹40 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 2.77 % |
Y-o-Y | 13.87 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 33.41% | 2.77 | |
Sep2023 | 32.51% | 8.77 | |
Jun2023 | 29.89% | -6.09 | |
Mar2023 | 31.83% | 8.49 | |
Dec2022 | 29.34% | 2.55 | |
Sep2022 | 28.61% | 12.02 | |
Jun2022 | 25.54% | -16.56 | |
Mar2022 | 30.61% | - |
ADVANCED ENZYME TECHNOLOGIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 20.76 % |
Y-o-Y | 52.28 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹43 Cr | 20.76 | |
Sep2023 | ₹35 Cr | 19.80 | |
Jun2023 | ₹29 Cr | -8.52 | |
Mar2023 | ₹32 Cr | 15.07 | |
Dec2022 | ₹28 Cr | 6.28 | |
Sep2022 | ₹26 Cr | 49.37 | |
Jun2022 | ₹18 Cr | -30.38 | |
Mar2022 | ₹25 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 18.43 % |
Y-o-Y | 34.47 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 26.41 % | 18.43 | |
Sep2023 | 22.3 % | 11.78 | |
Jun2023 | 19.95 % | -13.82 | |
Mar2023 | 23.15 % | 17.87 | |
Dec2022 | 19.64 % | 3.75 | |
Sep2022 | 18.93 % | 30.37 | |
Jun2022 | 14.52 % | -24.26 | |
Mar2022 | 19.17 % | - |
ADVANCED ENZYME TECHNOLOGIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 21.43 % |
Y-o-Y | 42.21 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹3.74 | 21.43 | |
Sep2023 | ₹3.08 | 19.38 | |
Jun2023 | ₹2.58 | -10.10 | |
Mar2023 | ₹2.87 | 9.13 | |
Dec2022 | ₹2.63 | 12.39 | |
Sep2022 | ₹2.34 | 46.25 | |
Jun2022 | ₹1.6 | -26.94 | |
Mar2022 | ₹2.19 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD